The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 6.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 33% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (17 analysts) rates it buy, with a mean price target of $458.
Marathon Petroleum
MPC · a US exchange · USD · Market cap $106.1B · 18,500 employees
Marathon Petroleum Corporation, together with its subsidiaries, operates as an integrated downstream energy company in the United States.
FAIL · Does not pass the screenPrice as of 19 Nov 2026Daily close, not a live quote
Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price367.93 USD at the 19 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 19 Nov 2026
- Our regime readDistribution, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans to puts (put/call 2.61)
- Last reviewed19 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $389.24 to $598.18, base estimate $492.50 (screen dated 2026-11-19).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning political selling, disclosed 2026-10-15
- Options put/call open interest 2.61, read 2026-11-19
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
Marathon Petroleum holds its Distribution at $367.93. Elevated stress, defensive posture warranted, held for 11 days.
| Phase | Distribution · caution |
| Quantitative state | Elevated stress, defensive posture warranted, held for 11 days |
| Price at the screen | $367.93 |
| Valuation | 7.72 trailing · 6.34 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.51 |
Five Screens: MPC's Results
FAIL. Debt ratio
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 40.92% | Below 33% | Fail |
| Interest-bearing cash | 8.09% | Below 33% | Pass |
| Receivables | 16.66% | Below 49% | Pass |
| Revenue purity | 0.12% | Below 5% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadWhy It Falls Short, in Plain English
Marathon Petroleum's business is in a permissible area, but its interest-bearing debt is about 41% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when MPC's ethical verdict changes
Today MPC does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 19 Nov 2026: it trades at roughly a 25% discount to our $492.50 fair value, weak competitive moat, 60.90% revenue growth.
Model construction and limits: fair-value methodology.
Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. A 25.3% discount to the base estimate.
Third-party analyst targets: 17 covering, consensus Buy. The average target sits +27% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $492.50, with a range of $389.24 to $598.18, dated to the 2026-11-19 screen.
How our estimate and third-party targets differ.
The Business, in Plain WordsUS refiner looks cheap but carries heavy debt
Every time crude prices spike, refiners book fat margins that vanish the moment demand softens or inventories build. We pass on Marathon because the 12.4 times forward multiple sits on what looks like peak-cycle earnings, not a durable edge, and the business carries a weak moat with just 3 percent profit margins despite 9 percent revenue growth.
Return on equity reaches 27 percent, yet that figure flatters a capital-heavy model exposed to oil swings. The shares trade 18 percent above our fair value of 256.78 against a 312.60 price, and the ethical screen flags the debt ratio as a clear failure.
Seventeen analysts still rate it a buy with a 300 median target, but cyclical value traps often appear cheapest right before earnings roll over. Debt adds fragility when fuel cracks narrow. Analysis, not advice.
| Forward P/E | 6.3xcheap for a company growing this fast |
| Trailing P/E | 7.7xvery cheap relative to earnings |
| EPS, trailing | 50.47 |
| EPS, forward | 61.42 |
| Revenue growth | +60.9%growing very fast |
| Profit margin | 8.3%thin but positive margins |
| Return on equity | 60.5%an exceptional return on shareholder capital |
| FCF yield | 15.31% |
| Dividend yield | 1.18% |
| Debt to equity | 1.15a meaningful debt load worth watching |
| Current ratio | 1.45adequate liquidity, worth monitoring |
| Beta | 0.51steadier than the market |
| Short interest, float | 0.03% |
| 52-week range | 161.93 - 493.98 |
| Moat | WEAK |
| Market cap | $106.1B |
| Employees | 18,500 |
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 12.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 33% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (17 analysts) rates it buy, with a mean price target of $467.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 70% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (18 analysts) rates it buy, with a mean price target of $459. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 70% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (18 analysts) rates it buy, with a mean price target of $459. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 70% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (18 analysts) rates it buy, with a mean price target of $459. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 70% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (18 analysts) rates it buy, with a mean price target of $459. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 5.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 70% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (18 analysts) rates it buy, with a mean price target of $459. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 4.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 70% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (18 analysts) rates it buy, with a mean price target of $459. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 70% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (18 analysts) rates it buy, with a mean price target of $459. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 70% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (18 analysts) rates it buy, with a mean price target of $459. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- 2 Dividend Stocks Could Generate $30,000 a Year, but the Allocation Matters Yahoo Finance · 14h ago
- Your Chevron Hedge Works Only While Oil Spikes Yahoo Finance · 18h ago
- Crude Gives Back Ground Midweek as Inventories Build and Surplus Talk Grows Yahoo Finance · 19h ago
- What Moved Marathon Petroleum Stock? Yahoo Finance · 21h ago
- What Sent Valero Energy Stock Lower? Yahoo Finance · 21h ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-13 | HESSLING RICKY D. | Officer | 1,000 | $250,000 | |
| 2026-04-30 | ELLISON-TAYLOR KIMBERLY N | Director | 727 | · | |
| 2026-04-30 | PATERSON EILEEN PATRICIA | Director | 727 | · | |
| 2026-04-30 | RUCKER KIM K. W. | Director | 727 | · | |
| 2026-04-30 | SEMPLE FRANK M | Director | 727 | · | |
| 2026-04-30 | SURMA JOHN P JR. | Director | 727 | · | |
| 2026-04-30 | COHEN JONATHAN Z | Director | 727 | · | |
| 2026-04-30 | STICE J MICHAEL | Director | 727 | · | |
| 2026-04-30 | CAMPBELL JEFFREY C | Director | 727 | · | |
| 2026-04-30 | BAYH B EVAN III | Director | 727 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-10-15 | David Taylor | Republican | sell | 1K–15K |
| 2026-10-15 | David Taylor | Republican | sell | 1K–15K |
| 2026-10-15 | David Taylor | Republican | sell | 1K–15K |
| 2026-10-15 | David Taylor | Republican | sell | 1K–15K |
| 2026-10-15 | David Taylor | Republican | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $473.69 | -21.1% | · | $789 | -21.1% |
| 2 months | $424.89 | -12.0% | · | $880 | -12.0% |
| 3 months | $358.23 | +4.4% | · | $1,044 | +4.4% |
| 6 months | $253.95 | +47.2% | $1.00 | $1,476 | +47.6% |
| 1 year | $196.33 | +90.4% | $4.00 | $1,925 | +92.5% |
| 2 years | $153.76 | +143.1% | $7.64 | $2,481 | +148.1% |
| 3 years | $140.17 | +166.7% | $10.12 | $2,739 | +173.9% |
| 5 years | $54.40 | +587.2% | $15.68 | $7,160 | +616.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever MPC does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.